Navigation Links
Aging kidneys may hold key to new high blood pressure therapies
Date:8/29/2012

HOUSTON, Aug. 29, 2012 Gaining new insight to managing sodium balance and blood pressure, investigators at the University of Houston (UH) College of Pharmacy believe their work may identify future therapeutic targets to control hypertension.

Mohammad Asghar, assistant professor of pharmacology, is exploring the mechanisms by which oxidative and inflammatory stressors considered hallmarks of the aging process alter the function of two critical receptor systems in the kidneys that are involved in sodium metabolism and blood pressure. While there are different hormonal systems in the body that aid in sodium balance, at the center of Asghar's research are the dopamine and angiotensin II receptor systems that play pivotal roles in fine-tuning sodium stability and maintaining normal blood pressure.

"When the function of these two receptor systems is defective, the equilibrium of sodium is disturbed, causing an increase in blood pressure," Asghar said. "Yet, it remains unclear as to what triggers the dysfunction of the receptors and their delicate balancing act."

In research conducted up to this point, supported by funding from the National Institutes of Health (NIH), Asghar and his collaborators have identified two likely factors inflammation and oxidative stress that have adverse effects on kidney functions. His results showed that exercise training builds up strong anti-inflammatory and antioxidant environments, thereby improving kidney functions during aging.

"We now are attempting to determine the mechanisms by which oxidative stress and inflammatory stress exert their actions upon these receptors and contribute to increased blood pressure," Asghar said. "We are currently investigating if exercise training has beneficial effects in improving dopamine and angiotensin II receptor functions, sodium balance and control of blood pressure during aging."

With this next phase of research funded by a five-year, $1.5 million grant from the NIH's National Institute on Aging, Asghar has set out to specifically examine resistant hypertension, which is a particular type of high blood pressure that does not respond to treatment.

"Resistant hypertension, which is typical of the aging phenomenon, requires a combination of drugs for blood pressure control," he said. "Currently available medications are not effective to treat resistant hypertensive patients. While my research is focused on aging, the outcomes may very well benefit both adult and older populations who suffer from hypertension."

Citing studies that have linked both a low-sodium diet and exercise to reducing oxidative and inflammatory stress, Asghar is a proponent of moderate, regular exercise and better dietary habits. In addition to further investigating the relationship between high salt and hypertension through his analyses of receptor systems in the kidneys, he also is looking at how exercise and antioxidant or anti-inflammatory therapeutic agents may restore the function of those two key receptors to reduce hypertension. He believes this exercise research could yield potential therapeutic targets that mimic exercise, which may prove beneficial for those individuals who are unable to exercise due to physical or other disabilities.

Asghar and his team's ongoing work could lead to new treatments for millions of hypertensive individuals at risk for stroke, heart failure and a range of other cardiovascular diseases due to high blood pressure, which is a major risk factor for these ailments.


'/>"/>
Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related biology news :

1. Imaging study sheds new light on alcohol-related birth defects
2. Selfish DNA in animal mitochondria offers possible tool to study aging
3. Carnegie Mellon study shows skin-aging radicals age naturally formed particles in the air
4. Anti-aging elixir for solar cells
5. Stanford-SLAC team uses X-ray imaging to observe running batteries in action
6. Microcirculation imaging
7. UCLA scientists discover how key enzyme involved in aging, cancer assembles
8. Grant program to spur new research on Alzheimers disease by encouraging collaboration
9. Managing biodiversity data from local government
10. WSU researchers say genes and vascular risk modify effects of aging on brain and cognition
11. Canadian girl, 16, invents disease-fighting, anti-aging compound using tree particles
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aging kidneys may hold key to new high blood pressure therapies
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... LiveWire Healthcare and Life Sciences Awards as "Most ... off an unprecedented year of recognition and growth for ... over 15 years. iMedNet ™ ...
(Date:11/16/2016)... 2016 Sensory Inc ., a ... for consumer electronics, and VeriTran , a ... industry, today announced a global partnership that will ... authenticate users of mobile banking and mobile payments ... software which requires no specialized biometric scanners, yet ...
(Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Biology News(10 mins):
(Date:12/9/2016)... Dec. 9, 2016 China Cord Blood Corporation (NYSE: ... China,s leading provider of cord blood collection, laboratory ... today announced the results of its 2016 Annual General Meeting, ... S.A.R., China . At ... the re-appointment of KPMG Huazhen LLP as the independent auditors ...
(Date:12/8/2016)...  The Board of Directors of the Pittsburgh ... only pure life sciences investment firm, today ... succession plan developed by the Nominating and Governance Committee ... (Jim) F. Jordan is selected to serve as ... Manzetti , who is elected to the position of ...
(Date:12/8/2016)... Dec. 8, 2016  OncoSec Medical Incorporated ("OncoSec") ... DNA-based intratumoral cancer immunotherapies, today announced financial results ... "We are delivering on our commitment to ... ImmunoPulse┬« IL-12. We are pleased with the early ... trial, and we are focused on advancing our ...
(Date:12/8/2016)... Dec. 8, 2016  Biotheranostics today announced that ... of the Breast Cancer Index (BCI) in identifying ... are most at-risk for disease recurrence and might ... from three studies advancing the understanding of the ... tumor biology and inform decisions related to patient ...
Breaking Biology Technology: